Treatment of Early-Stage Esophageal Adenocarcinoma
نویسندگان
چکیده
منابع مشابه
Treatment of early-stage esophageal adenocarcinoma.
Although T2,N0,M0 esophageal adenocarcinoma is grouped with other locoregional disease by NCCN, no consensus exists about how it should be treated. One of the inherent complexities of treating T2,N0,M0 esophageal adenocarcinoma is the inaccuracy of the clinical staging. In addition, conflicting evidence exists about whether neoadjuvant therapy adds any benefit to esophagectomy. A 52-year-old pa...
متن کاملSubcutaneous metastases from early stage esophageal adenocarcinoma case report
The identification of subcutaneous metastatic lesions from primary visceral malignancies has increased over time, probably due to an increase in the awareness of their presentation and an increase in cancer survival times. Although the rate of subcutaneous metastases from breast,lung and colon cancer is more significant, the incidence of subcutaneous metastases from esophageal carcinomas is ver...
متن کاملEndoscopic methods in the treatment of early-stage esophageal cancer
Most patients with early esophageal cancer restricted to the mucosa may be offered endoscopic therapy, which is similarly effective, less invasive and less expensive than esophagectomy. Selection of appropriate relevant treatment and therapy methods should be performed at a specialized center with adequate facilities. The selection of an endoscopic treatment method for high-grade dysplasia and ...
متن کاملTreatment of High-Grade Dysplasia and Early Stage Esophageal Adenocarcinoma with an Endoscope: The Ultimate in Minimally Invasive, Curative Therapy
There has been a radical paradigm shift away from esophagectomy as the standard of therapy for highgrade dysplasia and early esophageal cancer. A number of organ-sparing endoscopic procedures including endoscopic resection, radiofrequency ablation and cryoablation are emerging as viable and preferable options for the treatment of early esophageal neoplasia. This review article will discuss idea...
متن کاملDetection of early-stage pancreatic adenocarcinoma.
BACKGROUND Pancreatic adenocarcinoma is an almost universally lethal disease, in large part, due to our inability to detect early-stage disease. Monoclonal antibody PAM4 is reactive with a unique biomarker expressed by >85% of pancreatic adenocarcinomas. In this report, we examined the ability of a PAM4-based immunoassay to detect early-stage disease. MATERIALS AND METHODS The PAM4-based immu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the National Comprehensive Cancer Network
سال: 2013
ISSN: 1540-1405,1540-1413
DOI: 10.6004/jnccn.2013.0083